Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.36% | 198.32 | 1.3% | $525.50m | |
| GILD | Gilead Sciences, Inc. | 1.37% | 66.87 | 0.9% | $355.36m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.98% | 106.71 | 2.0% | $331.00m | |
| ILMN | Illumina, Inc. | 0.68% | 307.27 | 3.5% | $318.06m | |
| BIIB | Biogen Inc. | 2.52% | 241.55 | 1.3% | $313.76m | |
| CELG | Celgene Corporation | 0.57% | 99.52 | 1.3% | $296.26m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.51% | 178.80 | 1.9% | $177.39m | |
| A | Agilent Technologies, Inc. | 0.78% | 78.68 | 1.6% | $177.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.16% | 295.21 | 2.6% | $171.65m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.28% | 83.42 | 14.6% | $141.94m | |
| EXAS | Exact Sciences Corporation | -0.05% | 103.35 | 24.1% | $138.68m | |
| ACAD | ACADIA Pharmaceuticals Inc. | -2.12% | 40.80 | 13.9% | $122.79m | |
| INCY | Incyte Corporation | 2.30% | 79.92 | 2.5% | $87.16m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.05% | 18.65 | 10.2% | $76.37m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.15% | 76.11 | 4.3% | $75.73m |
Company Profile
Axovant Gene Therapies Ltd. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease. The company was founded on October 31, 2014 and is headquartered in London, United Kingdom.